Berg Media

BERG PRESENTS FIRST-IN-KIND DATA USING ITS BAYESIAN AI-DRIVEN INTERROGATIVE BIOLOGY® TECHNOLOGY TO MAP UNDERLYING BIOLOGY OF PATIENT RESPONSES IN ADVANCED SOLID TUMOR TRIAL OF BPM31510

October 3, 2019

BERG PRESENTS FIRST-IN-KIND DATA USING ITS BAYESIAN AI-DRIVEN INTERROGATIVE BIOLOGY® TECHNOLOGY TO MAP UNDERLYING BIOLOGY OF PATIENT RESPONSES IN ADVANCED SOLID TUMOR TRIAL OF BPM31510

Press releases

November 26, 2018

Drugmakers embracing AI’s utility to uncover hidden opportunities in discovery

News

November 24, 2018

Drugmakers embracing AI’s utility to uncover hidden opportunities in discovery

News

November 20, 2018

Pharma companies put faith in AI for breakthroughs

News

November 18, 2018

The State of AI in Pharmaceutical Drug Development

News
PRNewswire: BERG Presents Clinical Target Validation Data for the Treatment of Parkinson’s Disease and Novel Mechanism of Action in Neurological Disorders at Neuroscience 2018

November 7, 2018

PRNewswire: BERG Presents Clinical Target Validation Data for the Treatment of Parkinson’s Disease and Novel Mechanism of Action in Neurological Disorders at Neuroscience 2018

Press releases
PRNewswire: Berg Analytics to Present at the AMIA 2018 Annual Symposium

November 2, 2018

PRNewswire: Berg Analytics to Present at the AMIA 2018 Annual Symposium

Press releases

October 22, 2018

Fortune.com: 3 Ways AI Is Changing Healthcare

News
PRNewswire: BERG to Present New Data Describing Details on Progress of its Oncology Portfolio and Precision Medicine Applications at the European Society for Medical Oncology 2018 Congress

October 19, 2018

PRNewswire: BERG to Present New Data Describing Details on Progress of its Oncology Portfolio and Precision Medicine Applications at the European Society for Medical Oncology 2018 Congress

Press releases

October 10, 2018

STATNEWS.com: AI for drug development: Experts break down what’s possible — and what’s just hype

News

September 27, 2018

Glorikian.com: Niven Narain and How AI and Machine Learning are Changing Drug Discovery

News

September 14, 2018

MediaPlanet: “Rare Diseases Campaign”

News

August 22, 2018

Pharmaphorum: Artificial intelligence in drug discovery and diagnosis

News

August 22, 2018

HealthTech Outlook:

News

June 5, 2018

From Nature: Computer-Calculated Compounds

News

June 5, 2018

EB Treatment Candidate BPM 31510 Granted Orphan Drug Designation in US

News
BERG Showcases New Clinical Data on BPM 31510 at ASCO 2018

June 4, 2018

BERG Showcases New Clinical Data on BPM 31510 at ASCO 2018

Press releases
BERG Announces FDA Orphan-Drug Designation of BPM 31510 for the Treatment of Patients with Epidermolysis Bullosa

May 23, 2018

BERG Announces FDA Orphan-Drug Designation of BPM 31510 for the Treatment of Patients with Epidermolysis Bullosa

Press releases
BERG Announces FDA Orphan-Drug Designation of BPM 31510 for the Treatment of Patients with Epidermolysis Bullosa

May 23, 2018

BERG Announces FDA Orphan-Drug Designation of BPM 31510 for the Treatment of Patients with Epidermolysis Bullosa

Press releases
BERG Announces Data Presentations at AACR 2018 Validating Novel Prostate Cancer Biomarkers and Clinical Activity of BPM 31510 Across Several Metabolic Cancer Types

April 18, 2018

BERG Announces Data Presentations at AACR 2018 Validating Novel Prostate Cancer Biomarkers and Clinical Activity of BPM 31510 Across Several Metabolic Cancer Types

Press releases
BERG Announces the Dosing of First UK Patient in Phase II Combination Trial of BPM 31510 and Gemcitabine for Patients with Pancreatic Cancer

April 4, 2018

BERG Announces the Dosing of First UK Patient in Phase II Combination Trial of BPM 31510 and Gemcitabine for Patients with Pancreatic Cancer

Press releases